NCT07531082 · NOT YET RECRUITING
Effects of a Salutogenic Strength-based Social Robot-assisted Intervention on the Depressive Symptoms and Sense of Coherence of Family Caregivers of Persons With Dementia
This trial tests whether a social robot with an AI chatbot can reduce depression in family caregivers of people with dementia. Caregivers use the robot at home for six weeks while researchers measure mood, stress, and coping skills. This is a Phase NA behavioral trial, meaning it is evaluating whether the approach works, not testing a drug or medical device. It is a randomized controlled trial, so results will be compared against a control group receiving reading materials.
You may qualify if
- those aged 18 years or older;
- family caregivers of PwD who had been clinically diagnosed;
- are living in the same household as the PwD;
- providing daily caregiving for ≥ 4 hours /day;
- have mild-to-moderate depressive symptoms (PHQ-9 score of 5-14) (Yu et al., 2012); and
- are able to speak Cantonese.
You're excluded if
- those who have been diagnosed with a mental disorder such as bipolar disorder, schizophrenia, dementia, or depression in an acute stage;
- those with a visual or hearing impairment that would interfere with the use of a robot;
- those currently using a social robot at home; and
- who have limited access to electricity at home.
The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.
Eligibility criteria as of 2026-04-15